Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
1996-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7c9ba17579edb3ea4f2cc17bdb4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d74dbb46dcf7f6148ae7756f4438010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ac19e0a9a480c5db44776b11171a8af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dfabdb2dd931e1ba9aaf5ecf9aa5259 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_720a41244b1eec8619a671b066dc92f6 |
publicationDate |
1997-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2234763-A1 |
titleOfInvention |
Conjugates useful in the treatment of benign prostatic hyperplasia |
abstract |
Novel pharmaceutical compositions useful for the treatment of benign prostatic hyperplasia which comprises novel oligopeptides, which are selectively cleaved by enzymatically active PSA, in conjugation with a cytotoxic agent are described. Methods of treating benign prostate hypertrophy are also disclosed. |
priorityDate |
1995-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |